ANGO – Angiodynamic Inc
ANGO — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
3.6
Margin Of Safety %
-34
Put/Call OI Ratio
0.29
EPS Next Q Diff
-0.01
EPS Last/This Y
0.61
EPS This/Next Y
0.22
Price
15.69
Target Price
20
Analyst Recom
1
Performance Q
39.22
Upside
-298.5%
Beta
0.32
Ticker: ANGO
18 items
«
‹
of 1
›
»
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-07-14 | ANGO | 13 | 0.85 | 1.83 | 1766 |
| 2026-07-15 | ANGO | 14.48 | 0.83 | 0.09 | 1793 |
| 2026-07-16 | ANGO | 14.13 | 0.72 | 0.46 | 2034 |
| 2026-07-17 | ANGO | 13.49 | 0.79 | 1.16 | 1943 |
| 2026-07-20 | ANGO | 13.7 | 0.32 | 1.20 | 1100 |
| 2026-07-21 | ANGO | 14.2 | 0.31 | 0.33 | 1103 |
| 2026-07-22 | ANGO | 13.82 | 0.31 | 1.00 | 1107 |
| 2026-07-23 | ANGO | 13.42 | 0.32 | 0.00 | 1108 |
| 2026-07-24 | ANGO | 13.57 | 0.31 | 0.00 | 1120 |
| 2026-07-27 | ANGO | 13.64 | 0.31 | 0.00 | 1115 |
| 2026-07-28 | ANGO | 14.32 | 0.31 | 0.00 | 1136 |
| 2026-07-29 | ANGO | 14.6 | 0.27 | 0.00 | 1237 |
| 2026-07-30 | ANGO | 14.8 | 0.27 | 0.00 | 1237 |
| 2026-07-31 | ANGO | 14.77 | 0.27 | 0.00 | 1238 |
| 2026-08-03 | ANGO | 15.18 | 0.29 | 0.00 | 1196 |
| 2026-08-04 | ANGO | 15.23 | 0.29 | 5.00 | 1197 |
| 2026-08-05 | ANGO | 15.03 | 0.29 | 0.00 | 1201 |
| 2026-08-07 | ANGO | 15.7 | 0.29 | 0.00 | 1200 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
18 items
«
‹
Current Page1 of 1
›
»
19 items
«
‹
of 1
›
»
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-07-14 | ANGO | 12.99 | -100.0 | - | -0.20 |
| 2026-07-15 | ANGO | 14.47 | -100.0 | - | -0.20 |
| 2026-07-16 | ANGO | 14.15 | -100.0 | - | -0.22 |
| 2026-07-17 | ANGO | 13.49 | 3.3 | - | -0.22 |
| 2026-07-20 | ANGO | 13.70 | -5.0 | - | -0.22 |
| 2026-07-21 | ANGO | 14.21 | -5.0 | - | -0.27 |
| 2026-07-22 | ANGO | 13.84 | -5.0 | - | -0.27 |
| 2026-07-23 | ANGO | 13.43 | -5.0 | - | -0.27 |
| 2026-07-24 | ANGO | 13.59 | -13.3 | - | -0.27 |
| 2026-07-27 | ANGO | 13.64 | -13.3 | - | -0.27 |
| 2026-07-28 | ANGO | 14.32 | -13.3 | - | -0.27 |
| 2026-07-29 | ANGO | 14.61 | -13.3 | - | -0.27 |
| 2026-07-30 | ANGO | 14.78 | -13.3 | - | -0.27 |
| 2026-07-31 | ANGO | 14.76 | -13.3 | - | -0.27 |
| 2026-08-03 | ANGO | 15.18 | -13.3 | - | -0.27 |
| 2026-08-04 | ANGO | 15.18 | -13.3 | - | -0.27 |
| 2026-08-05 | ANGO | 15.05 | -13.3 | - | -0.27 |
| 2026-08-06 | ANGO | 15.11 | -13.3 | - | -0.27 |
| 2026-08-07 | ANGO | 15.69 | -13.3 | - | -0.27 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
19 items
«
‹
Current Page1 of 1
›
»
19 items
«
‹
of 1
›
»
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-07-14 | ANGO | 0.00 | -1.84 | 3.71 |
| 2026-07-15 | ANGO | 0.00 | -1.84 | 3.71 |
| 2026-07-16 | ANGO | 0.00 | -1.84 | 3.71 |
| 2026-07-17 | ANGO | 0.00 | -1.84 | 3.71 |
| 2026-07-20 | ANGO | 0.00 | -2.85 | 3.71 |
| 2026-07-21 | ANGO | 0.00 | -2.85 | 3.71 |
| 2026-07-22 | ANGO | 0.00 | -2.85 | 3.71 |
| 2026-07-23 | ANGO | 0.00 | -2.85 | 3.71 |
| 2026-07-24 | ANGO | 0.00 | -2.85 | 3.71 |
| 2026-07-27 | ANGO | 0.00 | -2.85 | 3.60 |
| 2026-07-28 | ANGO | 0.00 | -2.85 | 3.60 |
| 2026-07-29 | ANGO | 0.00 | -2.85 | 3.60 |
| 2026-07-30 | ANGO | 0.00 | -2.85 | 3.60 |
| 2026-07-31 | ANGO | 0.00 | -2.85 | 3.60 |
| 2026-08-03 | ANGO | -0.49 | -2.65 | 3.60 |
| 2026-08-04 | ANGO | -0.49 | -2.65 | 3.60 |
| 2026-08-05 | ANGO | -0.49 | -2.65 | 3.60 |
| 2026-08-06 | ANGO | -0.49 | -2.65 | 3.60 |
| 2026-08-07 | ANGO | -0.49 | -2.65 | 3.60 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
19 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-0.07
Avg. EPS Est. Current Quarter
-0.11
Avg. EPS Est. Next Quarter
-0.08
Insider Transactions
-0.49
Institutional Transactions
-2.65
Beta
0.32
Average Sales Estimate Current Quarter
80
Average Sales Estimate Next Quarter
84
Fair Value
10.28
Quality Score
50
Growth Score
49
Sentiment Score
89
Actual DrawDown %
51
Max Drawdown 5-Year %
-83
Target Price
20
P/E
Forward P/E
PEG
P/S
2.03
P/B
3.83
P/Free Cash Flow
EPS
-0.89
Average EPS Est. Cur. Y
-0.27
EPS Next Y. (Est.)
-0.05
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-11.48
Relative Volume
0.95
Return on Equity vs Sector %
-48.8
Return on Equity vs Industry %
-30.9
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.05
EBIT Estimation
◆
ANGO
Healthcare
$15.69
📉
Swing / Pullback
Buy the dip on strong trends
WEAK
Trend
20/20
Pullback
6/25
Volume
7/15
Valuation
10/20
TP/AR
2/10
Options
7/10
RSI
72.5
Range 1M
99.1%
Sup Dist
4.8%
🚀
Momentum Growth
Ride accelerating trends
WEAK
Momentum
21/25
Growth
16/30
Estimates
2/20
Inst/Vol
5/15
Options
8/10
EPS Yr
-77.8%
EPS NY
83.1%
52W%
99.6%
💎
N/A
Long-Term Value
Quality companies, undervalued
WEAK
🔴 SELL
-9.7% upside
Quality
5/30
Valuation
2/30
Growth
10/25
Stability
8/10
LT Trend
4/5
Upside
-9.7%
Quality
50
MoS
-34%
Click a card to see score breakdown
Full Analysis →
ANGO — P/E HistoricalMedical Instruments & Supplies
Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 632
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which include angiographic catheters, guidewires, drainage catheters, and micropuncture kits for use in invasive procedures. In addition, the company provides total abscession drainage catheters for multi-purpose/general and biliary configurations, and nephrostomy options; mini stick MAX Coaxial microintroducer kits and micro-introducer kits; ports; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.
ANGO
Latest News
—
Caricamento notizie per ANGO…
stock quote shares ANGO – Angiodynamic Inc Stock Price stock today
news today ANGO – Angiodynamic Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ANGO – Angiodynamic Inc yahoo finance google finance
stock history ANGO – Angiodynamic Inc invest stock market
stock prices ANGO premarket after hours
ticker ANGO fair value insiders trading